Achillion pharmaceuticals inc (ACHN)
CashFlow / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities
Net loss

-74,569

-70,870

-68,643

-70,272

-76,874

-80,328

-85,672

-85,236

-66,462

-67,854

-63,804

-61,706

-40,325

6,664

-3,821

-5,030

-43,578

-85,504

-72,183

-69,008

-60,762

-59,014

-63,297

-58,947

-56,801

-58,137

-49,724

-47,127

-48,308

-43,491

-43,214

-44,206

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

1,168

1,183

1,169

1,158

1,142

1,132

1,120

1,126

1,107

1,088

1,058

955

879

805

726

694

641

578

538

489

0

0

0

-

-

-

406

408

410

389

353

327

0

0

0

Non-cash stock-based compensation

6,745

6,649

8,611

9,380

9,705

10,499

9,732

10,573

11,070

11,352

11,206

11,006

10,888

10,374

10,131

10,072

10,001

9,387

8,634

7,273

6,356

6,030

6,053

5,920

5,583

5,284

4,435

3,932

3,674

3,398

3,261

2,989

0

0

0

Premium on purchases of marketable securities

-

-

-

59

0

0

0

-

-

-

-

565

592

1,727

1,692

2,486

2,086

1,582

1,445

947

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Premium on purchases of marketable securities

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of (discount) premium on marketable securities

2,350

2,203

1,531

641

-184

-863

-1,090

-1,079

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

0

0

0

Premium on purchases of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,376

3,967

3,863

755

0

0

0

-

-

-

-

Amortization of premium on marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

1,493

1,898

2,000

2,002

1,782

1,731

1,744

1,959

2,293

2,532

2,711

2,360

1,807

1,197

595

444

441

484

466

478

0

0

0

Changes in operating assets and liabilities:
Accounts and other receivables

154

97

866

290

-209

89

-109

-15,196

-94

-657

-458

14,750

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts and other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

6

-415

44

203

-427

183

572

174

370

73

-76

-143

0

0

0

Prepaid expenses and other assets

-699

-1,312

-1,654

242

-714

360

1,387

313

2,210

1,413

1,582

721

595

737

746

837

118

355

47

-575

-113

-696

-2,315

104

-329

516

1,227

757

257

28

-489

-739

0

0

0

Accounts payable

1,505

3,202

-411

-2,940

-6,520

-1,512

-1,628

-1,577

2,911

-2,570

-2,464

2,693

314

-5,920

-1,399

-2,285

2,278

9,398

4,299

1,827

-2,209

-4,557

-1,552

315

-1,021

1,693

297

-519

1,798

700

1,001

2,123

0

0

0

Operating lease right-of-use asset

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-852

1,925

1,503

107

605

11

-182

2,210

862

502

2,467

987

1,709

1,947

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,489

0

0

0

-

-

-

-

Accrued expenses and other liabilities

-

0

0

-

-

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-55,269

-

-64,116

6,685

6,714

5,577

5,015

-62,593

-59,487

-55,524

-53,319

-54,391

-53,824

-53,636

0

0

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-59,975

-56,505

-55,641

-62,012

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-43,361

-40,699

-39,240

-36,136

0

0

0

Cash flows from investing activities
Purchases of fixed assets

224

254

407

515

547

644

590

626

1,290

1,587

2,328

2,508

1,858

1,638

1,024

704

1,241

1,022

803

947

480

416

483

408

273

318

324

656

767

811

1,202

732

0

0

0

Purchases of marketable securities

-

0

226,346

-

-

261,268

286,098

345,490

360,767

376,916

448,273

499,115

624,831

779,370

655,880

692,525

482,261

268,270

246,928

79,338

88,408

78,197

89,888

168,117

157,220

191,861

173,006

79,759

78,352

94,021

95,986

79,706

0

0

0

Maturities of marketable securities

302,297

266,207

294,311

289,891

306,256

333,922

357,057

372,091

429,976

435,099

489,896

562,292

580,346

586,675

500,085

394,575

245,132

167,707

128,309

123,625

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

75,530

69,980

73,480

45,774

0

0

0

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

39,295

-

-46,343

-194,333

-156,819

-298,654

-238,370

-101,585

-119,422

43,340

58,095

68,982

48,341

-65,034

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by investing activities

63,317

55,873

67,558

66,316

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,589

-24,852

-23,708

-34,664

0

0

0

Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

2,053

1,883

1,911

1,341

39

0

0

0

-

-

-

-

3,730

3,573

5,631

4,589

4,067

4,185

1,707

453

555

589

1,439

1,327

2,378

2,185

1,327

1,687

570

0

0

0

Payment of deferred financing costs

-

-

-

-

-

-

-

175

0

0

0

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

229

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of debt

169

206

243

170

201

260

316

351

363

322

285

246

217

216

212

248

272

272

312

313

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Borrowings of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Repayments of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

232

184

103

546

0

0

0

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

308

-

390

159,727

162,127

301,138

344,176

192,608

191,511

52,391

9,204

1,440

206

133,601

0

0

0

-

-

-

-

-

-

-

-

Payment of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net cash provided by financing activities

3,934

387

652

2,029

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44,403

1,890

63,716

61,537

0

0

0

Net decrease in cash and cash equivalents

7,276

-245

12,569

6,333

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-15,666

-

-110,069

-27,921

12,022

8,061

110,821

28,430

12,602

40,207

13,980

16,031

-5,277

14,931

4,789

-1,027

9,909

2,416

-2,547

-63,661

768

-9,263

0

0

0

Supplemental disclosure of cash flow information
Cash paid for interest

29

33

33

37

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure of non-cash activities
Cash paid for interest

-

-

-

-

-

-

-

-

-

-

49

-

44

47

43

50

49

43

44

35

35

39

44

46

50

54

65

60

59

53

31

33

0

0

0

Cashless exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

53

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of fixed assets in accounts payable and accrued expenses

-

-

-

49

19

-5

24

36

-116

-184

-159

199

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use asset and liability (non-cash adoption balances)

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cashless exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-